Evidence map›Paper›PMID 39979455›Full record

ReviewLasers in medical science2025

Research trends and hotspots of laser therapy in hemangioma: a bibliometric and visualization analysis.

Jing Nie, Xiaoyang Dong, Dilinur Tasimeti, Yalin Zhu

Abstract readReview
In one paragraph

Review in Lasers in medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jing NieDepartment of Dermatology, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang, 830054, China.
Xiaoyang DongDepartment of Dermatology, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang, 830054, China.
Dilinur TasimetiDepartment of Dermatology, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang, 830054, China.
Yalin ZhuDepartment of Dermatology, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang, 830054, China. 294198014@qq.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This bibliometric analysis aimed to analyze global research trends in laser therapy for hemangiomas, a common benign vascular tumor in children from 1977 to 2024. Publications in laser therapy for hemangiomas from 1977 to 2024 were retrieved from the Web of Science Core Collection (WoSCC) database, and only articles published in English were analyzed. Bibliometric and visual analyses were performed using VOSviewer, CiteSpace, and the R package "bibliometrix." A total of 1,028 publications from 66 countries and 4,199 authors were analyzed, showing an annual growth rate of 5.61%. The United States led with 365 articles and 11,713 citations. Major contributors included the University of California System and Harvard Medical School, and key journals were Lasers in Surgery and Medicine and Dermatologic Surgery. Pulsed dye laser (PDL) was the most studied laser type. Research focused on optimizing treatment safety, effectiveness, and management, especially in children. The rise of propranolol as a keyword highlighted its increasing role in hemangioma therapy, and the keyword like "classification" and "vascular anomalies" underlining the importance of accurate diagnosis and classification. This study highlights the growing importance of laser therapies for hemangiomas. Future research should explore combining propranolol with laser treatments and the role of precise diagnosis in improving treatment outcomes.

Indexed as

BibliometricsHemangiomaLaser TherapyHumansLasers, DyePropranololPropranololBibliometric AnalysisHemangiomaLaser TherapyPulsed Dye Laser Therapy

Identifiers

PMID39979455
PMCPMC11842401

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.